LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
Recruiting · NCT07143110 · Observational (researchers observe without assigning treatment) · Lead sponsor: AstraZeneca
View the official record on ClinicalTrials.gov →What this trial is about
LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use/costs for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.
Who can take part
Age range
18 Years to 130 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients with lung cancer between January 1, 2018 and end of the Selection Period.
- Patient is 18 years of age or older on diagnosis date.
- Patient has at least 12 months of health insurance coverage prior to the diagnosis date.
Exclusion criteria
- Diagnosed with any other cancer in the 5-year period prior to January 1, 2018.
- Diagnosed with any other cancer concurrently (i.e., on the same date) as lung cancer diagnosis.
- Invalid or incomplete records for key variables (e.g., missing year of diagnosis, missing cancer type).
- Non-Ontario or non-Alberta resident on diagnosis date.
Where it is running
2 locations listed.
- Research Site - Calgary, Alberta, Canada
- Research Site - Toronto, Ontario, Canada